Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Andreas Desiniotis & Natasha Kyprianou. (2011) Advances in the design and synthesis of prazosin derivatives over the last ten years. Expert Opinion on Therapeutic Targets 15:12, pages 1405-1418.
Read now
Read now
Articles from other publishers (17)
Sepehr Golriz Khatami, Sarah Mubeen, Vinay Srinivas Bharadhwaj, Alpha Tom Kodamullil, Martin Hofmann-Apitius & Daniel Domingo-Fernández. (2021) Using predictive machine learning models for drug response simulation by calibrating patient-specific pathway signatures. npj Systems Biology and Applications 7:1.
Crossref
Crossref
Danying Zhang, Wenqing Tang, Shuqiang Weng, Ningping Zhang, Tiancheng Luo, Xizhong Shen & Ling Dong. (2020) Integrated in silico‐in vitro analysis of systematic kinase gatekeeper mutation effects on pan‐kinase inhibitors in targeted liver cancer therapy. Journal of the Chinese Chemical Society 68:4, pages 647-656.
Crossref
Crossref
Qie Guo, Zhong-Guo Sui, Wen Xu, Xiang-Hua Quan, Jia-Lin Sun, Xiao Li, Hong-Yan Ji & Fan-Bo Jing. (2017) Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells. Oncotarget 8:42, pages 72652-72665.
Crossref
Crossref
Yongjun Zhu, Min Song & Erjia Yan. (2016) Identifying Liver Cancer and Its Relations with Diseases, Drugs, and Genes: A Literature-Based Approach. PLOS ONE 11:5, pages e0156091.
Crossref
Crossref
Yan Duan, Winnie Wong, Sonja Chua, Hwee Wee, Seng Lim, Boon Chua & Han Ho. (2015) Overexpression of Tyro3 and its implications on hepatocellular carcinoma progression. International Journal of Oncology.
Crossref
Crossref
Jian Zhu, Yanping Wang, Yunhui Yu, Zheng Wang, Tingting Zhu, Xiukun Xu, Haiyan Liu, David Hawke, Dapeng Zhou & Yunsen Li. (2014) Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues. Liver International 34:1, pages 147-160.
Crossref
Crossref
Honglei Zhao, Xin Feng, Wenyu Han, Yuwen Diao, Dong Han, Xiaofeng Tian, Yu Gao, Shanshan Liu, Seng Zhu, Cuimei Yao, Jingmin Gu, Changjiang Sun & Liancheng Lei. (2013)
Enhanced binding to and killing of hepatocellular carcinoma cells
in vitro
by melittin when linked with a novel targeting peptide screened from phage display
. Journal of Peptide Science 19:10, pages 639-650.
Crossref
Crossref
Carolina Simioni, Alberto M. Martelli, Alice Cani, Rengul Cetin-Atalay, James A. McCubrey, Silvano Capitani & Luca M. Neri. (2013) The AKT Inhibitor MK-2206 is Cytotoxic in Hepatocarcinoma Cells Displaying Hyperphosphorylated AKT-1 and Synergizes with Conventional Chemotherapy. Oncotarget 4:9, pages 1496-1506.
Crossref
Crossref
Xue Zhao, Zhen Yang, GuangBing Li, DongKai Li, Yi Zhao, Yan Wu, Simon C. Robson, Lian He, YiYao Xu, RuoYu Miao & HaiTao Zhao. (2012) The role and clinical implications of microRNAs in hepatocellular carcinoma. Science China Life Sciences 55:10, pages 906-919.
Crossref
Crossref
Rajkumar Venkatramani, Wayne L. Furman, Joerg Fuchs, Steven W. Warmann & Marcio H. Malogolowkin. (2012) Current and Future Management Strategies for Relapsed or Progressive Hepatoblastoma. Pediatric Drugs 14:4, pages 221-232.
Crossref
Crossref
Bao-Hua Zou, Zheng Fang, Hui Zhong, Guo Kai & Ping Wei. (2012)
Phenyl
N
-(5-chloro-2-nitrophenyl)carbamate
. Acta Crystallographica Section E Structure Reports Online 68:8, pages o2547-o2547.
Crossref
Crossref
Hyo-Cheol Kim, Jin Wook Chung, Seung Hong Choi, Seock-Ah Im, Yasundo Yamasaki, Suryoung Jun, Hwan Jun Jae & Jae Hyung Park. (2010) Augmentation of Chemotherapeutic Infusion Effect by TSU-68, an Oral Targeted Antiangiogenic Agent, in a Rabbit VX2 Liver Tumor Model. CardioVascular and Interventional Radiology 35:1, pages 168-175.
Crossref
Crossref
Elizabeth Allen, Ian B. Walters & Douglas Hanahan. (2011) Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition. Clinical Cancer Research 17:16, pages 5299-5310.
Crossref
Crossref
David Berz & Harold Wanebo. (2011) Targeting the growth factors and angiogenesis pathways: Small molecules in solid tumors. Journal of Surgical Oncology 103:6, pages 574-586.
Crossref
Crossref
Li Chen, Yan Shi, Cheng-ying Jiang, Li-xin Wei, Ya-li Lv, Yu-lan Wang & Guang-hai Dai. (2018) Coexpression of PDGFR-Alpha, PDGFR-Beta and VEGF as a Prognostic Factor in Patients with Hepatocellular Carcinoma. The International Journal of Biological Markers 26:2, pages 108-116.
Crossref
Crossref
Kuen-Feng Chen, Hui-Ling Chen, Wei-Tien Tai, Wen-Chi Feng, Chih-Hung Hsu, Pei-Jer Chen & Ann-Lii Cheng. (2011) Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells. Journal of Pharmacology and Experimental Therapeutics 337:1, pages 155-161.
Crossref
Crossref
Stephanie Coulon, Femke Heindryckx, Anja Geerts, Christophe Van Steenkiste, Isabelle Colle & Hans Van Vlierberghe. (2011) Angiogenesis in chronic liver disease and its complications. Liver International 31:2, pages 146-162.
Crossref
Crossref